Moreover, as a mouse (m)-specific PXR ligand, PCN can relieve inflammatory injury through inhibiting NF-κB signaling in colitis mice, which suggests the potency of PXR activators as therapeutic agents for IBD patients10. Here, NFKB1 is linked to inflammatory bowel disease.